These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 30365048)
1. Deletion of FOXL2 by CRISPR promotes cell cycle G0/G1 restriction in KGN cells. Tang B; Zhang Y; Zhang W; Zhu Y; Yuan S Int J Mol Med; 2019 Jan; 43(1):567-574. PubMed ID: 30365048 [TBL] [Abstract][Full Text] [Related]
2. Estrogen regulates forkhead transcription factor 2 to promote apoptosis of human ovarian granulosa-like tumor cells. Wu J; Miao C; Lv X; Zhang Y; Li Y; Wang D J Steroid Biochem Mol Biol; 2019 Nov; 194():105418. PubMed ID: 31376461 [TBL] [Abstract][Full Text] [Related]
3. Transcriptome sequencing revealed that knocking down FOXL2 affected cell proliferation, the cell cycle, and DNA replication in chicken pre-ovulatory follicle cells. Luo W; Gu L; Li J; Gong Y PLoS One; 2020; 15(7):e0234795. PubMed ID: 32645018 [TBL] [Abstract][Full Text] [Related]
4. Differential apoptotic and proliferative activities of wild-type FOXL2 and blepharophimosis-ptosis-epicanthus inversus syndrome (BPES)-associated mutant FOXL2 proteins. Kim JH; Bae J J Reprod Dev; 2014 Mar; 60(1):14-20. PubMed ID: 24240106 [TBL] [Abstract][Full Text] [Related]
5. A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp. Herman L; Amo A; Legois B; Di Carlo C; Veitia RA; Todeschini AL Br J Cancer; 2024 May; 130(9):1453-1462. PubMed ID: 38429437 [TBL] [Abstract][Full Text] [Related]
6. CRISPR RNA-guided autonomous delivery of Cas9. Wilkinson RA; Martin C; Nemudryi AA; Wiedenheft B Nat Struct Mol Biol; 2019 Jan; 26(1):14-24. PubMed ID: 30598555 [TBL] [Abstract][Full Text] [Related]
7. Rapid construction of multiple sgRNA vectors and knockout of the Arabidopsis IAA2 gene using the CRISPR/Cas9 genomic editing technology. Liu DY; Qiu T; Ding XH; Li M; Zhu MY; Wang JH Yi Chuan; 2016 Aug; 38(8):756-64. PubMed ID: 27531614 [TBL] [Abstract][Full Text] [Related]
8. Improved genome editing in human cell lines using the CRISPR method. Munoz IM; Szyniarowski P; Toth R; Rouse J; Lachaud C PLoS One; 2014; 9(10):e109752. PubMed ID: 25303670 [TBL] [Abstract][Full Text] [Related]
9. SeqCor: correct the effect of guide RNA sequences in clustered regularly interspaced short palindromic repeats/Cas9 screening by machine learning algorithm. Liu X; Yang Y; Qiu Y; Reyad-Ul-Ferdous M; Ding Q; Wang Y J Genet Genomics; 2020 Nov; 47(11):672-680. PubMed ID: 33451939 [TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas9 Genome Editing in Human Cell Lines with Donor Vector Made by Gibson Assembly. Sahoo N; Cuello V; Udawant S; Litif C; Mustard JA; Keniry M Methods Mol Biol; 2020; 2115():365-383. PubMed ID: 32006411 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of single guide RNA transcription for efficient CRISPR/Cas-based genomic engineering. Ui-Tei K; Maruyama S; Nakano Y Genome; 2017 Jun; 60(6):537-545. PubMed ID: 28177825 [TBL] [Abstract][Full Text] [Related]
12. The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary. Jamieson S; Butzow R; Andersson N; Alexiadis M; Unkila-Kallio L; Heikinheimo M; Fuller PJ; Anttonen M Mod Pathol; 2010 Nov; 23(11):1477-85. PubMed ID: 20693978 [TBL] [Abstract][Full Text] [Related]